Katie Kosko

African-Americans who received a racially matched liver had better survival outcomes compared with unmatched patients, according to a review of national data.

Penn Medicine launches program that allows people with brain tumors to access remote medical plans.

Although chemotherapy and radical cystectomy are traditionally used to treat muscle-invasive disease, a recent analysis shows similar overall survival outcomes in patients treated with chemoradiotherapy.

Half of patients diagnosed with advanced non-small cell lung cancer were alive 6.8 years after diagnosis, according to new study findings.

The Food and Drug Administration has approved Nplate for pediatric patients 1 year of age and older with immune thrombocytopenia who have had an insufficient response to medications, such as corticosteroids,or surgery to remove the spleen.

A new program offers counseling, patient education and vetted referrals to patients and their families.

A team of chronic lymphocytic lymphoma experts address patients’ concerns about this long-term illness, such as securing financial help.

November is Lung Cancer Awareness Month, and our Lung Cancer Special Issue is offering new insights into the treatment of the disease.

Jeff Young, D.V.M., refused to let cancer stop him from living.

Survivor diagnosed with second cancer after surgeon spots a lump on her throat while watching TV.

Immunotherapy may lead to a major change in how the treatment of metastatic recurrent head and neck cancer is approached, according to Barbara Burtness, M.D., a professor of medicine at Yale School of Medicine.

Although immunotherapies show promise for patients, there are still challenges ahead.

Younger women who were treated with the cancer therapy saw their menstrual cycles end within a year of diagnosis.

Palliative care may reduce the risk of suicide in veterans who receive a diagnosis of stage 3b or 4 lung cancer, according to the findings of a new study.

Partners who remain close during cancer-related discussions may protect the person with the disease from experiencing increased symptom burden.

A fateful drive led one woman to a clinical trial where lung cancer was discovered.

Two treatments that may help patients with a potentially deadly blood cancer live longer and prevent the incidence of thrombosis (blood clots) are being underused.

Researchers have found a potentially safer and faster way to determine if treatment for a type of childhood brain cancer is working.

Patients with BRAF wild-type advanced melanoma saw a survival benefit after treatment with Opdivo (nivolumab) compared with the chemotherapy agent dacarbazine.

The combination use of two immunotherapy agents in the first-line setting helped patients with advanced melanoma live longer compared with treatment with either drug alone.

We've got a sneak peek at what’s inside our Fall 2018 issue.

Preventing febrile neutropenia is crucial because the body’s white blood cells help to fight infection.

Imbruvica (ibrutinib) is a safe treatment for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL), according to a pooled analysis of four clinical trials.

Lock Up Lung Cancer is a new campaign to expose the disease as a prolific killer, according to LUNG FORCE.

Many patients with lung cancer may experience side effects, such as fatigue and shortness of breath, that can prevent them from exercising. However, for the first time, new research findings showed benefits from exercise in those with advanced disease.

Many patients with renal cell carcinoma, the most common type of kidney cancer, experience high levels of distress, according to study findings published in BJU International.

After receiving a breast cancer diagnosis, the news anchor reveals the ways in which she is forever changed.

Patients can use daily practices to help reduce stress and anxiety.

Patients can apply topical skin treatments in moderation before radiation therapy despite common advice from health care providers not to, according to study findings published in JAMA Oncology.

Treating older patients who have Hodgkin lymphoma with Adcetris (brentuximab vedotin) before and after chemotherapy showed improved remission and survival rates, according to phase 2 study findings.